Figure 2

Coherus Oncology Fig 2

Second-line ESCC/EAC swimmer plot from TREGCHECK™ 102 Cohorts A (2L EAC) and B (2L ESCC). Median Progression-Free Survival was 5.5 months. Data as of October 14, 2026

Format

PNG

Source

Coherus Oncology, Inc.

Downloads